Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
DNA, RNA & Cells
Filter     Order     Display # 
Date Item Title
17 Nov 2008 InteRNA Technologies and Cenix BioScience Ink Research Agreement for miRNA Drug Discovery
13 Nov 2008 ZaBeCor's Investigational New Drug Application Approved by the FDA
11 Nov 2008 Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
10 Nov 2008 Celgene Cellular Therapeutics Receives FDA Clearance for First Placenta-Derived Stem Cell Clinical Study
06 Nov 2008 Pervasis Therapeutics Presents Safety Data from Phase 1 and 2 Clinical Trials of Vascugel(R) at the American Society of Nephrology Annual Meeting
04 Nov 2008 Genzyme and Osiris Partner to Develop and Commercialize First-in-Class Adult Stem Cell Products
04 Nov 2008 Alnylam and Collaborators Publish Research on a New Class of Chemically Modified RNAi Therapeutics that Target Two Distinct Cellular Mechanisms
30 Oct 2008 StemCells, Inc. Announces Preclinical Results Showing its Proprietary Human Neural Stem Cells Can Prevent Vision Loss
29 Oct 2008 Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic
28 Oct 2008 Geron Scientists and Collaborators Demonstrate Activity of Pancreatic Islet-like Cells Derived from Human Embryonic Stem Cells in Diabetes
27 Oct 2008 Ophthotech Enrolls First Patient in a Phase I Complement (Anti-C5) Inhibitor Trial for Macular Degeneration
23 Oct 2008 Novo Nordisk, Cellartis and Lund University enter into a collaboration to develop insulin-producing cells from stem cells for the treatment of diabetes
20 Oct 2008 Geron Initiates Clinical Trial of GRN163L in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma
20 Oct 2008 Enzon Presents New Data on Its LNA Programs
20 Oct 2008 Archemix Signs Aptamer Therapeutics Agreement with Lilly
15 Oct 2008 Geron's GRN163L Sensitizes Resistant Breast Cancer Cells to Trastuzumab in Preclinical Study
15 Oct 2008 ATL1101 suppresses tumour growth in key mouse models of prostate cancer
14 Oct 2008 Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
14 Oct 2008 Athersys Announces Initial Patient Dosing of MultiStem(r) in Phase I Acute Myocardial Infarction Trial
14 Oct 2008 RXi Pharmaceuticals Obtains an Exclusive Worldwide License to Technology for the Oral Delivery of RNAi Therapeutics from the University of Massachuset
13 Oct 2008 Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
13 Oct 2008 OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011
12 Oct 2008 First Heart Failure Patients Successfully Implanted with Angioblast Systems’ “Off-the-Shelf” Adult Stem Cells
10 Oct 2008 AVONTEC announces the results of a successful proof of concept within a phase 2a study with its drug candidate AVT-02 UE ointment after topical treatment in patients with mild-to-moderate psoriasis
08 Oct 2008 Moraga Announces Licensing Agreement with Pharmacells, Ltd
07 Oct 2008 MDRNA, Inc. Advances RNAi Pipeline With Selection of Lead Candidate for Hypercholesterolemia Program
05 Oct 2008 AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R)
29 Sep 2008 Stratatech Successfully Completes Clinical Trial of StrataGraft(R) Skin Substitute
24 Sep 2008 Osiris Completes Enrollment of Stem Cell Trial to Treat Pulmonary Disease
23 Sep 2008 iCo Therapeutics Provides Interim Trial Results (Diffuse Diabetic Macular Edema)
22 Sep 2008 ATL/TV1102 Trial Results Presented at World Congress on Treatment and Research in Multiple Sclerosis
21 Sep 2008 Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy
18 Sep 2008 AMT Obtains License to Amgen's GDNF Gene to Develop Treatment for Parkinson's Disease with AMT's Proprietary Gene Therapy Platform
15 Sep 2008 Calando Pharmaceuticals Announces Next siRNA Therapeutic Candidate for Oncology
15 Sep 2008 Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma
15 Sep 2008 Sangamo BioSciences Announces Presentation of Data From Diabetic Neuropathy Clinical Trials
10 Sep 2008 Cell Medica announces treatment of first patient in late stage clinical trial of adoptive cell therapy
10 Sep 2008 Argos Therapeutics Initiates Phase 2 Trial in Renal Cell Carcinoma for its Arcelis(TM) Personalized Immunotherapy Platform
10 Sep 2008 Pluristem Successfully Concludes Final Pre-Clinical Safety Studies with PLX-PAD in Preparation for Human Trials
09 Sep 2008 Oxford BioMedica Announces Promising Interim Phase I/II Results of Prosavin(R) in Parkinson's Disease
08 Sep 2008 Bostwick Therapeutics Announces Initiation of Novel Phase I/II Personalized Medicine Immunotherapy Trial for Advanced Prostate Cancer
07 Sep 2008 OncoMune Publishes Positive Results of OCM-8054
04 Sep 2008 Antisoma starts phase II trial of AS1411 in renal cancer
03 Sep 2008 Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
02 Sep 2008 Introgen Receives Notice ADVEXIN(R) U.S. BLA Not Sufficiently Complete to File
02 Sep 2008 Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
01 Sep 2008 Diamyd Medical's NTDDS Technology Effective Against Diabetes Pain
26 Aug 2008 Novosom AG acquires exclusive license from Isis Pharmaceuticals, Inc. for CD40-targeted antisense inhibitors
25 Aug 2008 Isolagen Reports Positive Results from Open Label, Phase II Study of Isolagen Therapy(TM) of the Full Face Regarding the Treatment of Wrinkles and Skin Quality Characteristics
22 Aug 2008 Mesoblast's allogenic, "off the shelf", stem cells are safe and effective for cervical spine fusion
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 1 - 50 of 641

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics